Introduction:
The global market for hepatitis vaccines is expected to see significant growth in the coming years, with China emerging as a key player in the industry. With the increasing awareness about the importance of vaccination and the rising prevalence of hepatitis infections, the demand for vaccines is on the rise. In 2026, China is set to become a major producer of hepatitis vaccines, with several companies leading the way in production and innovation.
Top 10 Hepatitis Vaccine Producers in China 2026:
1. Sinovac Biotech Ltd.
Sinovac Biotech Ltd. is a leading Chinese biopharmaceutical company specializing in vaccine development. With a production volume of 10 million doses per year, Sinovac is a key player in the hepatitis vaccine market in China. The company’s commitment to research and development has positioned it as a top producer in the country.
2. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is another major player in the hepatitis vaccine market in China. With a market share of 15% and exports to over 50 countries, Wantai is known for its high-quality vaccines and innovative products. The company’s state-of-the-art facilities and focus on research have helped it gain a competitive edge in the market.
3. Shanghai United Family Hospital
Shanghai United Family Hospital is a renowned healthcare provider in China that has established itself as a top producer of hepatitis vaccines. With a production volume of 5 million doses per year, the hospital’s commitment to patient care and research has made it a trusted name in the industry.
4. China National Pharmaceutical Group Corporation (Sinopharm)
Sinopharm is a state-owned enterprise in China that plays a crucial role in the production of hepatitis vaccines. With a market share of 20% and exports to over 100 countries, Sinopharm is a key player in the global vaccine market. The company’s strong research and development capabilities have helped it maintain its position as a top producer in China.
5. Hualan Biological Engineering Inc.
Hualan Biological Engineering Inc. is a leading biopharmaceutical company in China that specializes in vaccine production. With a production volume of 8 million doses per year, Hualan is known for its high-quality vaccines and commitment to innovation. The company’s focus on research and development has helped it become a top player in the hepatitis vaccine market.
6. Changchun BCHT Biotechnology Co., Ltd.
Changchun BCHT Biotechnology Co., Ltd. is a key player in the hepatitis vaccine market in China. With a market share of 10% and exports to over 30 countries, BCHT is known for its cutting-edge vaccines and commitment to quality. The company’s state-of-the-art facilities and strong research capabilities have helped it establish itself as a top producer in the country.
7. Livzon Pharmaceutical Group Inc.
Livzon Pharmaceutical Group Inc. is a leading pharmaceutical company in China that has made significant contributions to the hepatitis vaccine market. With a production volume of 6 million doses per year, Livzon is known for its high-quality vaccines and commitment to research. The company’s focus on innovation and patient care has helped it gain a competitive edge in the industry.
8. China National Biotec Group (CNBG)
CNBG is a state-owned enterprise in China that is a major player in the hepatitis vaccine market. With a market share of 18% and exports to over 80 countries, CNBG is known for its high-quality vaccines and strong research capabilities. The company’s commitment to innovation and quality has helped it maintain its position as a top producer in the country.
9. Shenzhen Kangtai Biological Products Co., Ltd.
Shenzhen Kangtai Biological Products Co., Ltd. is a leading biopharmaceutical company in China that specializes in vaccine production. With a production volume of 7 million doses per year, Kangtai is known for its high-quality vaccines and commitment to research. The company’s state-of-the-art facilities and focus on innovation have helped it establish itself as a top producer in the hepatitis vaccine market.
10. Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a key player in the hepatitis vaccine market in China. With a market share of 12% and exports to over 40 countries, Tianyuan is known for its high-quality vaccines and commitment to patient care. The company’s focus on research and development has helped it gain a competitive edge in the industry.
Insights:
The hepatitis vaccine market in China is poised for significant growth in the coming years, driven by factors such as increasing awareness about vaccination, rising prevalence of hepatitis infections, and government initiatives to expand immunization programs. With the top 10 producers leading the way in innovation and production, China is set to become a major player in the global vaccine market. As the country continues to invest in research and development, we can expect to see further advancements in vaccine technology and an expansion of China’s role in the global healthcare industry.
Related Analysis: View Previous Industry Report
